Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Sales | 337 | 375 | 439 | 497 | 515 |
| Gross Profit | 330 | 370 | 450 | 490 | 510 |
| Operating Expenses | 2,770 | 2,220 | 3,870 | 3,890 | 3,310 |
| Operating Income | -2,433 | -1,845 | -3,431 | -3,393 | -2,795 |
| Other Income | -7 | -5 | 11 | -7 | -5 |
| Pre-tax Income | -2,440 | -1,850 | -3,420 | -3,400 | -2,800 |
| Net Income Continuous | -2,444 | -1,744 | -3,400 | -3,403 | -2,806 |
| Net Income | $-2,444 | $-1,744 | $-3,400 | $-3,403 | $-2,806 |
| EPS Basic Total Ops | -57.62 | -40.82 | -79.23 | -79.23 | -67.23 |
| EPS Basic Continuous Ops | -57.64 | -41.04 | -79.25 | -79.32 | -66.02 |
| EPS Diluted Total Ops | -57.62 | -40.82 | -79.23 | -79.23 | -67.23 |
| EPS Diluted Continuous Ops | -57.64 | -41.04 | -79.25 | -79.32 | -66.02 |
| EBITDA(a) | $-2,413 | $-1,835 | $-3,421 | $-3,383 | $-2,775 |